S2383 Assessing Gastrointestinal Bleeding Risk in Cirrhosis: A Multivariable Analysis Using a Nationally Representative Cohort

Introduction: Gastrointestinal (GI) bleeding is a common and potentially life-threatening complication of cirrhosis. While portal hypertension is a well-known driver, the role of comorbid conditions and social determinants in bleeding risk is less clearly defined. Using the diverse and nationally representative All of Us Research Program, we sought to identify clinical and demographic predictors of GI bleeding among patients with cirrhosis. Methods: A cross-sectional analysis was performed using the All of Us Registered Tier Dataset version 7. Adults with cirrhosis were identified using International Classification of Diseases, Tenth Revision codes and stratified into 2 cohorts: those with a diagnosis of GI bleeding following their cirrhosis diagnosis and those without a diagnosis of GI bleeding. A multivariable logistic regression model was constructed to assess associations between clinical and demographic factors and the likelihood of GI bleeding in cirrhosis. Demographic variables included age, sex, race, and income. Clinical factors included smoking, alcohol use, obesity, diabetes, hypertension, hyperlipidemia, and heart disease. Results: Overall, 7,297 participants with cirrhosis were included, of whom 2,386 had a documented GI bleed following cirrhosis diagnosis and 4,911 did not. Patients with GI bleeding were older and more likely to be woman. Several comorbidities were independently associated with increased odds of GI bleeding, including hypertension (OR 1.61, 95% CI 1.36–1.90, P < 0.001), heart disease (OR 1.72, 95% CI 1.42–2.10, P < 0.001), hyperlipidemia (OR 1.19, 95% CI 1.04–1.37, P = 0.014), and obesity (OR 1.17, 95% CI 1.03–1.33, P = 0.014). Female sex (OR 1.31, 95% CI 1.17–1.48, P < 0.001) was also associated with greater bleeding risk. Higher income was associated with lower odds of GI bleeding, with those earning over $100,000 having significantly reduced odds (OR 0.71, 95% CI 0.55–0.91, P = 0.007). Smoking, diabetes, and racial groups were not significantly associated. Conclusion: Our study found that common cardiovascular comorbidities including hypertension, heart disease, hyperlipidemia, and obesity were strongly associated with increased odds of GI bleeding. The protective effect of higher income underscores the role of socioeconomic status in shaping clinical outcomes, reflecting differences in access to care, surveillance, and management of chronic disease. Future work is needed to explore whether targeting modifiable comorbidities and addressing social determinants of health can mitigate bleeding risk in cirrhotic populations.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001136992.06346.ef
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S2383 Assessing Gastrointestinal Bleeding Risk in Cirrhosis: A Multivariable Analysis Using a Nationally Representative Cohort

Viknesh Baskar, Rebhi Rabah, Sushil K. Ahlawat
The American Journal of Gastroenterology
Liver Disease and Transplantation
article

S2383 Assessing Gastrointestinal Bleeding Risk in Cirrhosis: A Multivariable Analysis Using a Nationally Representative Cohort

Viknesh Baskar, Rebhi Rabah, Sushil K. Ahlawat
article en

Abstract

Introduction: Gastrointestinal (GI) bleeding is a common and potentially life-threatening complication of cirrhosis. While portal hypertension is a well-known driver, the role of comorbid conditions and social determinants in bleeding risk is less clearly defined. Using the diverse and nationally representative All of Us Research Program, we sought to identify clinical and demographic predictors of GI bleeding among patients with cirrhosis. Methods: A cross-sectional analysis was performed using the All of Us Registered Tier Dataset version 7. Adults with cirrhosis were identified using International Classification of Diseases, Tenth Revision codes and stratified into 2 cohorts: those with a diagnosis of GI bleeding following their cirrhosis diagnosis and those without a diagnosis of GI bleeding. A multivariable logistic regression model was constructed to assess associations between clinical and demographic factors and the likelihood of GI bleeding in cirrhosis. Demographic variables included age, sex, race, and income. Clinical factors included smoking, alcohol use, obesity, diabetes, hypertension, hyperlipidemia, and heart disease. Results: Overall, 7,297 participants with cirrhosis were included, of whom 2,386 had a documented GI bleed following cirrhosis diagnosis and 4,911 did not. Patients with GI bleeding were older and more likely to be woman. Several comorbidities were independently associated with increased odds of GI bleeding, including hypertension (OR 1.61, 95% CI 1.36–1.90, P < 0.001), heart disease (OR 1.72, 95% CI 1.42–2.10, P < 0.001), hyperlipidemia (OR 1.19, 95% CI 1.04–1.37, P = 0.014), and obesity (OR 1.17, 95% CI 1.03–1.33, P = 0.014). Female sex (OR 1.31, 95% CI 1.17–1.48, P < 0.001) was also associated with greater bleeding risk. Higher income was associated with lower odds of GI bleeding, with those earning over $100,000 having significantly reduced odds (OR 0.71, 95% CI 0.55–0.91, P = 0.007). Smoking, diabetes, and racial groups were not significantly associated. Conclusion: Our study found that common cardiovascular comorbidities including hypertension, heart disease, hyperlipidemia, and obesity were strongly associated with increased odds of GI bleeding. The protective effect of higher income underscores the role of socioeconomic status in shaping clinical outcomes, reflecting differences in access to care, surveillance, and management of chronic disease. Future work is needed to explore whether targeting modifiable comorbidities and addressing social determinants of health can mitigate bleeding risk in cirrhotic populations.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 48%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.